CureVac’s Collaboration with GSK

Baker McKenzie advised CureVac on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), restructured its existing collaboration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Atos’ Acquisition of Ipsotek

Baker McKenzie advised Atos on the deal. Atos completed the acquisition of Ipsotek, a leading AI enhanced video analytics software provider. With this acquisition, Atos, already a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Atos’ Acquisition of Ipsotek

Baker McKenzie advised Atos on the deal. Atos completed the acquisition of Ipsotek, a leading AI enhanced video analytics software provider. With this acquisition, Atos, already a...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Atos’ Acquisition of Cryptovision

Baker McKenzie advised Atos on the deal. Atos completed the acquisition of cryptovision, a leader in state-of-the-art cryptographic products and solutions for securing digital identities. cryptovision...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here